AREPANRIX H5N1
AREPANRIX H5N1
Approved
DIN Number
02401886
Drug Class
Human
Market Date
Mar 21, 2025
Company
HC
ID Biomedical Corporation of Quebec
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02401886
AIG Number0162701002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HAEMAGGLUTININ-STRAIN A (H5N1)Active
Strength: 3.75 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H5N1)